CVCO vs REGN · P/E 23, rev $2.24B vs P/E 14, rev $4.29B
Cavco Industries Inc (CVCO) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Cavco Industries Inc (CVCO) is a residential construction company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CVCO revenue for 2026-03-28 was $2.24B. Net income was $190.6M. Revenue was up 11.4% from 2025-03-29 to 2026-03-28. CVCO currently screens at market cap $4.23B and trailing P/E 22.9.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CVCO currently screens at market cap $4.23B and trailing P/E 22.9. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CVCO and REGN stock pages for the full models.
Not investment advice.